基于卤代乙脒的蛋白质精氨酸脱亚氨酶4（PAD4）失活剂的改进合成方法。
An improved synthesis of haloaceteamidine-based inactivators of protein arginine deiminase 4 (PAD4).
作者信息
Causey Corey P, Thompson Paul R
机构信息
Departent of Chemstry and Biochemistry, University of South Carolina, 631 Sumter Street, Columbia, SC 29208.
出版信息
Tetrahedron Lett. 2008 Jul 7;49(28):4383-4385. doi: 10.1016/j.tetlet.2008.05.021.
Abstract
Protein arginine deiminase 4 (PAD4) is an enzyme that hydrolyzes peptidyl arginine residues to form citrulline and ammonia. This enzyme has been implicated in several disease states, e.g. rheumatoid arthritis, and therefore represents a unique target for the development of a novel therapeutic. A solution-phase synthesis of Cl-amidine, the most potent PAD4 inactivator described to date, has been developed. This synthesis proceeds in 80% yield over 4 steps at a significantly (12-fold) lower cost.
摘要
蛋白质精氨酸脱亚氨酶4（PAD4）是一种将肽基精氨酸残基水解以形成瓜氨酸和氨的酶。这种酶与多种疾病状态有关，例如类风湿性关节炎，因此是新型治疗药物开发的独特靶点。已开发出迄今为止描述的最有效的PAD4灭活剂Cl-脒的溶液相合成方法。该合成方法以80%的产率分4步进行，成本显著降低（12倍）。
相似文献
1
An improved synthesis of haloaceteamidine-based inactivators of protein arginine deiminase 4 (PAD4).基于卤代乙脒的蛋白质精氨酸脱亚氨酶4（PAD4）失活剂的改进合成方法。
Tetrahedron Lett. 2008 Jul 7;49(28):4383-4385. doi: 10.1016/j.tetlet.2008.05.021.
2
Inhibitors and inactivators of protein arginine deiminase 4: functional and structural characterization.蛋白质精氨酸脱亚氨酶4的抑制剂和失活剂：功能与结构表征
Biochemistry. 2006 Oct 3;45(39):11727-36. doi: 10.1021/bi061180d.
3
Screening of natural inhibitors against peptidyl arginine deiminase 4 from herbal extracts by a high-performance liquid chromatography ultraviolet-visible based method.基于高效液相色谱紫外可见检测法从草药提取物中筛选抗肽基精氨酸脱亚氨酶4的天然抑制剂
J Chromatogr A. 2024 Feb 8;1716:464643. doi: 10.1016/j.chroma.2024.464643. Epub 2024 Jan 11.
4
Applicability of Small-Molecule Inhibitors in the Study of Peptidyl Arginine Deiminase 2 (PAD2) and PAD4.小分子抑制剂在肽基精氨酸脱亚氨酶 2（PAD2）和 PAD4 研究中的适用性。
Front Immunol. 2021 Oct 19;12:716250. doi: 10.3389/fimmu.2021.716250. eCollection 2021.
5
Development and use of clickable activity based protein profiling agents for protein arginine deiminase 4.开发和使用可点击反应的活性蛋白质组分析试剂用于蛋白质精氨酸脱亚氨酶 4。
ACS Chem Biol. 2011 May 20;6(5):466-76. doi: 10.1021/cb1003515. Epub 2011 Feb 7.
6
Substrate specificity and kinetic studies of PADs 1, 3, and 4 identify potent and selective inhibitors of protein arginine deiminase 3.PAD1、3 和 4 的底物特异性和动力学研究鉴定出了蛋白精氨酸脱亚氨酶 3 的有效且选择性抑制剂。
Biochemistry. 2010 Jun 15;49(23):4852-63. doi: 10.1021/bi100363t.
7
Theoretical study of the mechanism of protein arginine deiminase 4 (PAD4) inhibition by F-amidine.F-脒对蛋白质精氨酸脱亚氨酶4（PAD4）抑制机制的理论研究
J Mol Graph Model. 2015 Feb;55:25-32. doi: 10.1016/j.jmgm.2014.10.014. Epub 2014 Nov 7.
8
Activity-based protein profiling reagents for protein arginine deiminase 4 (PAD4): synthesis and in vitro evaluation of a fluorescently labeled probe.用于蛋白质精氨酸脱亚氨酶4（PAD4）的基于活性的蛋白质谱试剂：一种荧光标记探针的合成与体外评估
J Am Chem Soc. 2006 Nov 15;128(45):14468-9. doi: 10.1021/ja0656907.
9
Haloacetamidine-based inactivators of protein arginine deiminase 4 (PAD4): evidence that general acid catalysis promotes efficient inactivation.基于卤乙酰胺的蛋白质精氨酸脱亚氨酶 4（PAD4）抑制剂：普遍酸催化促进有效失活的证据。
Chembiochem. 2010 Jan 25;11(2):161-5. doi: 10.1002/cbic.200900698.
10
Synthesis and Biological Evaluation of an Indazole-Based Selective Protein Arginine Deiminase 4 (PAD4) Inhibitor.一种基于吲唑的选择性蛋白精氨酸脱亚氨酶4（PAD4）抑制剂的合成与生物学评价
ACS Med Chem Lett. 2018 Sep 14;9(10):1013-1018. doi: 10.1021/acsmedchemlett.8b00283. eCollection 2018 Oct 11.
引用本文的文献
1
Targeting rheumatoid arthritis: a molecular perspective on biologic therapies and clinical progress.靶向类风湿关节炎：生物疗法与临床进展的分子视角
J Biol Eng. 2025 Jul 24;19(1):67. doi: 10.1186/s13036-025-00534-8.
2
Protein citrullination: inhibition, identification and insertion.蛋白质瓜氨酸化：抑制、鉴定与插入。
Philos Trans R Soc Lond B Biol Sci. 2023 Nov 20;378(1890):20220240. doi: 10.1098/rstb.2022.0240. Epub 2023 Oct 2.
3
Diverse stimuli engage different neutrophil extracellular trap pathways.多种刺激可激活不同的中性粒细胞胞外诱捕网途径。
Elife. 2017 Jun 2;6:e24437. doi: 10.7554/eLife.24437.
4
Looking for the best anti-colitis medicine: A comparative analysis of current and prospective compounds.寻找最佳抗结肠炎药物：当前及潜在化合物的比较分析
Oncotarget. 2017 Jan 3;8(1):228-237. doi: 10.18632/oncotarget.13894.
5
Molecular targeting of protein arginine deiminases to suppress colitis and prevent colon cancer.蛋白质精氨酸脱亚氨酶的分子靶向作用以抑制结肠炎并预防结肠癌。
Oncotarget. 2015 Nov 3;6(34):36053-62. doi: 10.18632/oncotarget.5937.
6
Inhibiting protein arginine deiminases has antioxidant consequences.抑制蛋白精氨酸脱亚氨酶具有抗氧化作用。
J Pharmacol Exp Ther. 2015 Apr;353(1):64-70. doi: 10.1124/jpet.115.222745. Epub 2015 Jan 29.
7
Design, synthesis, and biological evaluation of tetrazole analogs of Cl-amidine as protein arginine deiminase inhibitors.作为蛋白质精氨酸脱亚氨酶抑制剂的Cl-脒基四唑类似物的设计、合成及生物学评价
J Med Chem. 2015 Feb 12;58(3):1337-44. doi: 10.1021/jm501636x. Epub 2015 Jan 16.
8
Peptidylarginine deiminase inhibition disrupts NET formation and protects against kidney, skin and vascular disease in lupus-prone MRL/lpr mice.肽基精氨酸脱亚氨酶抑制可破坏狼疮易感MRL/lpr小鼠的中性粒细胞胞外陷阱形成，并预防肾脏、皮肤和血管疾病。
Ann Rheum Dis. 2015 Dec;74(12):2199-206. doi: 10.1136/annrheumdis-2014-205365. Epub 2014 Aug 7.
9
Interrogation of the Active Sites of Protein Arginine Deiminases (PAD1, -2, and -4) Using Designer Probes.使用设计探针探究蛋白质精氨酸脱亚氨酶（PAD1、-2和-4）的活性位点
ACS Med Chem Lett. 2013 Jan 15;4(2):249-53. doi: 10.1021/ml300377d. eCollection 2013 Feb 14.
10
Peptidylarginine deiminase inhibition reduces vascular damage and modulates innate immune responses in murine models of atherosclerosis.肽基精氨酸脱亚氨酶抑制减少动脉粥样硬化小鼠模型的血管损伤并调节固有免疫反应。
Circ Res. 2014 Mar 14;114(6):947-56. doi: 10.1161/CIRCRESAHA.114.303312. Epub 2014 Jan 14.
本文引用的文献
1
Peptidyl arginine deiminase type 2 (PAD-2) and PAD-4 but not PAD-1, PAD-3, and PAD-6 are expressed in rheumatoid arthritis synovium in close association with tissue inflammation.2型肽基精氨酸脱亚氨酶（PAD-2）和PAD-4在类风湿性关节炎滑膜中表达，而PAD-1、PAD-3和PAD-6不表达，且其表达与组织炎症密切相关。
Arthritis Rheum. 2007 Nov;56(11):3541-53. doi: 10.1002/art.22983.
2
PADI4 polymorphisms and rheumatoid arthritis susceptibility: a meta-analysis.PAID4基因多态性与类风湿性关节炎易感性：一项荟萃分析
Rheumatol Int. 2007 Jul;27(9):827-33. doi: 10.1007/s00296-007-0320-y. Epub 2007 Jan 31.
3
Modulation of peptidyl arginine deiminase 2 and implication for neurodegeneration.肽基精氨酸脱亚氨酶2的调节及其与神经退行性变的关系
Curr Eye Res. 2006 Dec;31(12):1063-71. doi: 10.1080/02713680600991437.
4
Inhibitors and inactivators of protein arginine deiminase 4: functional and structural characterization.蛋白质精氨酸脱亚氨酶4的抑制剂和失活剂：功能与结构表征
Biochemistry. 2006 Oct 3;45(39):11727-36. doi: 10.1021/bi061180d.
5
Very recent onset rheumatoid arthritis: clinical and serological patient characteristics associated with radiographic progression over the first years of disease.极早期类风湿关节炎：疾病最初几年中与影像学进展相关的临床及血清学患者特征
Rheumatology (Oxford). 2007 Feb;46(2):342-9. doi: 10.1093/rheumatology/kel237. Epub 2006 Aug 9.
6
Proteomics implicates peptidyl arginine deiminase 2 and optic nerve citrullination in glaucoma pathogenesis.蛋白质组学表明肽基精氨酸脱亚氨酶2和视神经瓜氨酸化与青光眼发病机制有关。
Invest Ophthalmol Vis Sci. 2006 Jun;47(6):2508-14. doi: 10.1167/iovs.05-1499.
7
A fluoroacetamidine-based inactivator of protein arginine deiminase 4: design, synthesis, and in vitro and in vivo evaluation.一种基于氟乙脒的蛋白质精氨酸脱亚氨酶4失活剂：设计、合成以及体外和体内评价
J Am Chem Soc. 2006 Feb 1;128(4):1092-3. doi: 10.1021/ja0576233.
8
A functional haplotype of the PADI4 gene associated with increased rheumatoid arthritis susceptibility in Koreans.与韩国人类风湿性关节炎易感性增加相关的PADI4基因功能性单倍型。
Arthritis Rheum. 2006 Jan;54(1):90-6. doi: 10.1002/art.21536.
9
Replication of putative candidate-gene associations with rheumatoid arthritis in >4,000 samples from North America and Sweden: association of susceptibility with PTPN22, CTLA4, and PADI4.在来自北美和瑞典的4000多个样本中对类风湿关节炎假定候选基因关联进行复制研究：易感性与蛋白酪氨酸磷酸酶非受体型22（PTPN22）、细胞毒性T淋巴细胞相关抗原4（CTLA4）和肽基精氨酸脱亚氨酶4（PADI4）的关联。
Am J Hum Genet. 2005 Dec;77(6):1044-60. doi: 10.1086/498651. Epub 2005 Nov 1.
10
Expression of peptidylarginine deiminase type 4 (PAD4) in various tumors.4型肽基精氨酸脱亚氨酶（PAD4）在各种肿瘤中的表达。
Mol Carcinog. 2006 Mar;45(3):183-96. doi: 10.1002/mc.20169.
Zotero 插件